Advancements in Alzheimers disease [Ad hoc announcement pursuant to Art. 53 LR] Roche provides update on Phase III GRADUATE programme evaluating gantenerumab in early Alzheimer’s disease Roche - Nov 14, 2022 • November 15, 2022 View Content